C-4′ vinyl ether with a greater tendency to form a cation
than the C-1′ acetal, and a purine with multiple Lewis basic
sites. Radical cyclization to form the C-5′,6′ bond is an
interesting possibility. On the basis of our familiarity with
the synthesis of complex nucleoside antibiotics,7 we con-
sidered both early and late introduction of the purine but
found more success with late purine attachment even though
this necessitated installation of the reactive vinyl ether later
still.
7, but the most success was realized with 0.05 M n-Bu3SnH
in refluxing benzene. Under these conditions, two products,
8 and 9 (Scheme 2), were formed in a 3:2 ratio and 82%
Scheme 2. Radical Cyclization and CdC Protectiona
A C-5′ (griseolic acid numbering) vinyl radical precursor
was assembled from the commercial D-allo-furanose 3 as
shown in Scheme 1. Aldehyde 4 was converted to vinyl
Scheme 1. Synthesis of the Radical Cyclization Substratea
a Conditions: (j) PhSH, AIBN, CHCl3, NaHCO3, reflux; (k)
H2SO4, HOAc, Ac2O, CH2Cl2, 0 °C.
combined yield. The ratio was essentially unchanged at
n-Bu3SnH concentrations from 0.02 to 0.33 M. No other
product was discernible by TLC or NMR analysis. Charac-
terization of 8 and 9 as 6-endo-trig and 5-exo-trig cyclization
products, respectively, followed from 1H NMR analysis, and
the stereochemistry of each was established unambiguously
by X-ray crystallography. Thus, 9 matches the required
griseolic acid stereochemistry at C-6′.
The stereoselectivity of the cyclization of 6 is remarkable.
The presumed intermediate vinyl radical in 7 (Scheme 1)
must add, in the endo mode, to the re face of C-b in the
maleate alkene to set the stereochemistry at C-6′ of 8 (dashed
arrow), and in the exo mode to the opposite maleate face of
C-a (also re) to set the stereochemistry at C-6′ of 9 (solid
arrow). Subsequent hydrogen atom abstraction from the less
hindered â-face sets the stereochemistry at C-7′ of 8. In other
words, the maleate face that is exposed to the vinyl radical
determines both the stereochemistry and ring size of the
products. Possible interconversion of homoallylic radical
intermediates is ruled out by the concentration studies and
by stereoelectronic considerations.10
a Conditions: (a) t-BuPh2SiCl, imidazole, DMF; (b) aqueous
HOAc; (c) NaIO4, aqueous THF; (d) NH2NH2, EtOH; (e) I2, Et2O,
tetramethylguanidine; (f) DBU, toluene, 60 °C; (g) n-Bu4NF, THF;
(h) LiN(SiMe3)2 (0.2 equiv), Et2O, diethyl acetylenedicarboxylate;
(i) n-Bu3SnH, AIBN, benzene, 80 °C.
iodide 5 (95:5 mixture of isomers) by iodination of the
derived hydrazone,8 and then deprotection at O-3′ and
addition of this hydroxyl to diethyl acetylenedicarboxylate
under basic conditions afforded maleate derivative 6. The E
geometry is assigned on the basis of the vinyl-H chemical
shift (5.36 ppm).9 Iodine atom abstraction from 6 should give
vinyl radical 7.
For the synthesis to proceed from 9, temporary protection
of the CdC is required. This was accomplished by radical
addition of thiophenol to C-5′ (Scheme 2). Chloroform
proved to be a superior solvent for this addition, and NaHCO3
was added to neutralize any trace of acid that might promote
competing Markovnikov addition. In the best case the
reaction was run to half-completion, and unreacted 9 was
recycled. An easily separable mixture of thiophenol adducts
10 was obtained: the structure of 10-endo was proven
crystallographically, while 10-exo was taken on by acetolysis
to the anomeric acetate 11.
A variety of reducing reagents, initiators, solvents, con-
centrations, and temperatures were tried in order to generate
(4) Murofushi, Y.; Kimura, M.; Iijima, Y.; Yamazaki, M.; Kaneko, M.
Chem. Pharm. Bull. 1987, 35, 1036-1043. Murofushi, Y.; Kimura, M.;
Iijima, Y.; Yamazaki, M., Kaneko, M. Chem. Pharm. Bull. 1987, 35, 4442-
4453. Murofushi, Y.; Kimura, M.; Iijima, Y.; Yamazaki, M.; Kaneko, M.
Chem. Pharm. Bull. 1988, 36, 1309-1320. Murofushi, Y.; Kimura, M.;
Kuwano, H.; Iijima, Y.; Yamazaki, M.; Kaneko, M. Chem. Pharm. Bull.
1988, 36, 3760-3769.
(5) Tulshian, D.; Doll, R. J.; Stansberry, M. F. J. Org. Chem. 1991, 56,
6819-6822. Tulshian, D.; Czarniecki, M.; Doll, R. J.; Ahn, H.-S. J. Med.
Chem. 1993, 36, 1210-1220.
Vorbru¨ggen glycosylation11 of 11 (Scheme 3) with bis-
(trimethylsilyl)-N6-benzoyladenine in refluxing acetonitrile
(6) Tulshian, D. B.; Czarniecki, M. J. Am. Chem. Soc. 1995, 117, 7009-
7010.
(7) Knapp, S. Chem. ReV. 1995, 95, 1859-1876.
(8) Barton, D. H. R.; Bashiardes, G.; Fourrey, J.-L. Tetrahedron Lett.
1983, 24, 1605-1608.
(10) Beckwith, A. L. J.; O’Shea, D. M. Tetrahedron Lett. 1986, 27,
4525-4528. Stork, G.; Mook, R., Jr. Tetrahedron Lett. 1986, 27, 4529-
4532.
(9) Tobey, S. W. J. Org. Chem. 1969, 34, 1281-1298. Feit, B.-A.; Haag,
B.; Kast, J.; Schmidt, R. R. J. Chem. Soc., Perkin Trans. 1 1986, 2027-
2036.
(11) Vorbru¨ggen, H.; Ruh-Polenz, C. Org. React. 2000, 55, 1-630.
3584
Org. Lett., Vol. 3, No. 22, 2001